Laboratory Test Detail

Last Updated: November 11, 2019 @ 10:13 am

93657

Carcinogenic HPV

Specimen:Collect:
  • Genital Swab in Liquid Pap Media
Submit:
  • Genital Swab in Liquid Pap Media. Submit Ambient.
Special Handling:
  • State Source
  • Collect according to Liquid-Based Pap instructions. Add on testing for Pap Vials: ThinPrep- 30 days from collection date. SurePath- 14 days from collection date.
Rejection Criteria:
  • Specimen collected in a improper storage container
  • Other swabs will be rejected
Stability:Ambient: 1 Month(s); Refrigerated: 1 Month(s); Frozen: Unacceptable; Incubated: Unacceptable
Methodology:
  • The Aptima HPV Assay is an in vitro nucleic acid amplification test for the qualitative detection of viral mRNA from high-risk types of HPV in cervical specimens.
Performed:Mon-Fri
Reported:5-6 Day(s)
CPT Codes:
  • 87624
Interpretive Data:Please see report for interpretive data.

The Aptima HPV Assay is an in vitro nuclei acid amplification test for the qualitative detection of E6/E7 viral messenger RNA (mRNA) from 14 high-risk types of human papillomavirus (HPV) in cervical specimens. The high-risk types detected by the assay include: 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, and 68. The analytical performance characteristics of this assay, when used to test Surepath specimens, have been determined by Medical Lab Associates.The use of this test is indicated for screening women 21 years and older with ASCUS cervical cytology results. In woman 30 years and older, the assay can be used adjunctively with cervical cytology to guide patient management.
Components:
  • 93659 - SOURCE
  • 93658 - HPV DNA, HIGH RISK
Print Friendly, PDF & Email

Disclaimer:
It is preferable to locate tests on the website and not rely on printed test information, which may soon be out of date.
Updated test information can only be guaranteed by using this website.